Leerink analysts lifted J&J shares to a buy equivalent from hold on Wednesday, citing the company's slate of new drugs.
Get this delivered to your inbox, and more info about our products and services.
Shares of J&J rose about 1% Tuesday, shaking off their premarket declines.
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…
Things may be turning around for one of the most beaten-down parts of the stock market.
The investment bank upgraded the pharmaceutical name to buy from neutral.
The investment bank upgraded the pharma stock to overweight from equal weight.
The investment firm upgraded the cosmetics giant to buy from hold.
